Clinical trials
Esophageal Neoplasms trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
| Completed | 5 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Instituto do Cancer do Estado de São Paulo | 5 |
| Merck Sharp & Dohme LLC | 5 |
| AstraZeneca | 2 |
| Fauze Maluf Filho | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Eurofarma Laboratorios S.A. | 1 |
| Instituto Nacional de Cancer, Brazil | 1 |
| Jazz Pharmaceuticals | 1 |
| Novartis Pharmaceuticals | 1 |
| Universidade Federal de Pernambuco | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Neoplasms | 20 |
| Stomach Neoplasms | 6 |
| Head and Neck Neoplasms | 4 |
| Adenocarcinoma | 3 |
| Prostatic Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Deglutition Disorders | 2 |
| Esophageal Squamous Cell Carcinoma | 2 |
| Kidney Neoplasms | 2 |
| Neoplasms | 2 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.